Professional Summary
Professional Overview
Fernando Rodrigo is an experienced Finance Director and Chief Financial Officer (CFO) with a strong track record of driving financial strategy and excellence across the pharmaceutical and consumer goods industries. With expertise in financial management, business planning, and operational optimization, he has made significant contributions to the success of leading global organizations.
Experience Summary
Current Role
As the Finance Director and CFO at Teva Pharmaceuticals since June 2024, Fernando is responsible for overseeing the company's financial operations, strategic planning, and risk management. He plays a pivotal role in ensuring financial stability, driving cost optimization initiatives, and aligning financial strategies with the organization's overall business objectives.
Career Progression
Prior to his current role, Fernando served as the Director Financiero and CFO at LVMH's perfumes and cosmetics division from 2019 to 2024. In this position, he spearheaded financial transformation efforts, implemented robust cost control measures, and drove the integration of advanced analytics to enhance decision-making.
Before that, Fernando held various finance leadership roles at GlaxoSmithKline (GSK) and Novartis Vaccines, where he excelled in financial planning, working capital management, and business analysis. He also gained valuable entrepreneurial experience as a business owner, further strengthening his understanding of financial best practices and strategic decision-making.
Academic Background
Fernando holds a Bachelor's degree in Business Administration from the University of Buenos Aires, Argentina.
Areas of Expertise
- Financial management and reporting
- Strategic planning and business partnering
- Cost optimization and operational efficiency
- Working capital and cash flow management
- Financial transformation and digitalization
- Cross-functional collaboration and team leadership
Professional Impact
Throughout his career, Fernando has consistently delivered tangible results for the organizations he has served. At LVMH, he led a successful cost optimization initiative that resulted in a 15% reduction in operational expenses. At GSK, he played a pivotal role in streamlining the company's working capital management, which improved cash flow by 20% and reduced days sales outstanding by 12 days.
Conclusion
With his extensive experience, strategic mindset, and commitment to financial excellence, Fernando Rodrigo is a highly valuable asset to Teva Pharmaceuticals. His ability to drive financial transformation, optimize operations, and align financial strategies with business objectives positions him as a respected leader and trusted financial advisor within the pharmaceutical industry.
